Teledermatology in the diagnosis of melanoma

Journal of Telemedicine and Telecare

Volumn 20, Issue 1, 2014, Pages 18-23

  Karavan, Mahsa ^a,b   Compton, Nicholas ^a,b   Knezevich, Stevan ^a,c   Raugi, Gregory ^a,b   Kodama, Samantha ^a   Taylor, Leslie ^a   Reiber, Gayle E ^a,c  

^a VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; AMBULATORY CARE; DERMATOLOGY; EARLY DIAGNOSIS; EPIDEMIOLOGY; FEMALE; HUMAN; INCIDENCE; MALE; MELANOMA; MITOSIS; PATHOLOGY; PRIMARY HEALTH CARE; PROCEDURES; PROGNOSIS; REPRODUCIBILITY; RETROSPECTIVE STUDY; RURAL HEALTH CARE; SEVERITY OF ILLNESS INDEX; SKIN NEOPLASMS; STATISTICS AND NUMERICAL DATA; TELECONSULTATION; TREATMENT OUTCOME; UNITED STATES; VETERANS HEALTH;

AGED; DERMATOLOGY; EARLY DETECTION OF CANCER; FEMALE; HUMANS; INCIDENCE; MALE; MELANOMA; MITOSIS; NORTHWESTERN UNITED STATES; OFFICE VISITS; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PRIMARY HEALTH CARE; PROGNOSIS; REMOTE CONSULTATION; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; RURAL HEALTH SERVICES; SEVERITY OF ILLNESS INDEX; SKIN NEOPLASMS; UNITED STATES; VETERANS HEALTH;

EID: 84898873382     PISSN: 1357633X     EISSN: 17581109     Source Type: Journal    
DOI: 10.1177/1357633X13517354     Document Type: Article

References (22)

1. Moreno-Ramirez D,Ferrandiz L,Nieto-Garcia A, et al.Store-and-forward teledermatology in skin cancer triage: experience and evaluation of 2009 teleconsultations.Arch Dermatol. 2007;143:479-84.
2. Tan E,Yung A,Jameson M,Oakley A,Rademaker M.Successful triage of patients referred to a skin lesion clinic using teledermoscopy (IMAGE IT trial).Br J Dermatol. 2010;162:803-11.
3. Warshaw EM,Hillman YJ,Greer NL, et al.Teledermatology for diagnosis and management of skin conditions: a systematic review.J Am Acad Dermatol. 2011;64:759-72.
4. Massone C,Wurm EM,Hofmann-Wellenhof R,Soyer HP.Teledermatology: an update.Semin Cutan Med Surg. 2008;27:101-5.
5. Eminović N,de Keizer NF,Wyatt JC, et al.Teledermatologic consultation and reduction in referrals to dermatologists: a cluster randomized controlled trial.Arch Dermatol. 2009;145:558-64.
6. Center for Disease Control and Prevention. Basic information about skin cancer. See http://www.cdc.gov/cancer/skin/basic_info/ (last checked 27 August 2013).
7. Tsang MW,Resneck JS.Even patients with changing moles face long dermatology appointment wait-times: a study of simulated patient calls to dermatologists.J Am Acad Dermatol. 2006;55:54-8.
8. Ferrándiz L,Ruiz-de-Casas A,Martin-Gutierrez FJ, et al.Effect of teledermatology on the prognosis of patients with cutaneous melanoma.Arch Dermatol. 2012;148:1025-8.
9. Mahendran R,Goodfield MJ,Sheehan-Dare RA.An evaluation of the role of a store-and-forward teledermatology system in skin cancer diagnosis and management.Clin Exp Dermatol. 2005;30:209-14.
10. Loane MA,Bloomer SE,Corbett R, et al.A comparison of real-time and store-and-forward teledermatology: a cost-benefit study.Br J Dermatol. 2000;143:1241-7.
11. Warshaw EM,Lederle FA,Grill JP, et al.Accuracy of teledermatology for pigmented neoplasms.J Am Acad Dermatol. 2009;61:753-65.
12. Eastman KL,Lutton MC,Raugi GJ, et al.A teledermatology care management protocol for tracking completion of teledermatology recommendations.J Telemed Telecare. 2012;18:374-8.
13. National Cancer Institute. Surveillance Epidemiology and End Results (SEER) Program. Calculating Age-adjusted Rates. See http://seer.cancer.gov/statfacts/html/melan.html (last checked 27 August 2013).
14. National Cancer Institute. Surveillance Epidemiology and End Results (SEER) Program. Age-adjusted SEER Incidence Rates, 2006-2010, By Registry, Race and Sex. See http://seer.cancer.gov/csr/1975_2010/browse_csr.php?section=16&page=sect_16_table.16.html (last checked 27 August 2013).
15. Viola KV,Tolpinrud WL,Gross CP,Kirsner RS,Imaeda S,Federman DG.Outcomes of referral to dermatology for suspicious lesions: implications for teledermatology.Arch Dermatol. 2011;147:556-60.
16. Karjalainen JM,Eskelinen MJ,Nordling S,Lipponen PK,Alhava EM,Kosma VM.Mitotic rate and S-phase fraction as prognostic factors in stage I cutaneous malignant melanoma.Br J Cancer. 1998;77:1917-25.
17. Barnhill RL,Fine JA,Roush GC,Berwick M.Predicting five-year outcome for patients with cutaneous melanoma in a population-based study.Cancer. 1996;78:427-32.
18. Ronan SG,Han MC,Das Gupta TK.Histologic prognostic indicators in cutaneous malignant melanoma.Semin Oncol. 1988;15:558-65.
19. Clark WH,Elder DE,Guerry D, et al.Model predicting survival in stage I melanoma based on tumor progression.J Natl Cancer Inst. 1989;81:1893-904.
20. Murali R,Haydu LE,Long GV, et al.Clinical and pathologic factors associated with distant metastasis and survival in patients with thin primary cutaneous melanoma.Ann Surg Oncol. 2012;19:1782-9.
21. Wiener M,Acland KM,Shaw HM, et al.Sentinel node positive melanoma patients: prediction and prognostic significance of nonsentinel node metastases and development of a survival tree model.Ann Surg Oncol. 2010;17:1995-2005.
22. van Dijk MC,Aben KK,van Hees F, et al.Expert review remains important in the histopathological diagnosis of cutaneous melanocytic lesions.Histopathology. 2008;52:139-46.